OncoCyte Corporation (OCX)

OncoCyte Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	44	21	38	200	161	117
Market Cap Growth	-42.44%	-45.76%	-80.98%	24.52%	37.45%	108.38%
Enterprise Value	39	12	19	170	160	100
PE Ratio	-	-0.72	-0.52	-3.12	-5.37	-5.21
PS Ratio	31.04	13.74	39.74	91.06	132.18	-
PB Ratio	3.70	1.01	1.11	3.07	4.80	3.79
P/FCF Ratio	-1.39	-0.89	-0.76	-5.24	-5.91	-5.67
P/OCF Ratio	-1.38	-0.89	-0.84	-5.57	-6.19	-5.93
EV/Sales Ratio	28.19	8.24	20.35	77.46	131.45	-
EV/EBITDA Ratio	-0.53	-0.48	-0.29	-2.47	-5.23	-4.61
EV/EBIT Ratio	-0.51	-0.45	-0.27	-2.33	-5.17	-4.54
EV/FCF Ratio	-1.16	-0.53	-0.39	-4.46	-5.88	-4.87
Debt / Equity Ratio	0.29	0.14	0.10	0.09	0.26	0.19
Debt / EBITDA Ratio	-0.09	-0.11	-0.05	-0.08	-0.28	-0.27
Debt / FCF Ratio	-0.19	-0.12	-0.07	-0.15	-0.32	-0.29
Quick Ratio	0.89	1.61	1.99	2.62	1.08	5.06
Current Ratio	0.79	1.49	2.11	2.77	1.03	5.17
Asset Turnover	0.02	0.02	0.01	0.01	0.02	0
Interest Coverage	-703.37	-533.25	-877.34	-350.00	-122.75	-74.00
Return on Equity (ROE)	-144.40%	-82.30%	-116.80%	-68.60%	-82.90%	-68.00%
Return on Assets (ROA)	-51.90%	-35.20%	-51.10%	-40.40%	-50.70%	-59.00%
Return on Capital (ROIC)	-269.74%	-107.71%	-47.57%	-75.78%	-70.55%	-60.47%
Earnings Yield	-95.25%	-139.08%	-192.85%	-32.03%	-18.62%	-19.18%
FCF Yield	-40.64%	-112.59%	-131.09%	-19.08%	-16.93%	-17.64%
Buyback Yield / Dilution	-38.59%	-38.10%	-24.61%	-35.80%	-27.65%	-35.52%
Total Shareholder Return	-38.59%	-38.10%	-24.61%	-35.80%	-27.65%	-35.52%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).